Dr. Satish Ramalingam, Ph.D

PDF: Nova SouthEastern University, USA; Washington University USA; University of Oklahoma,USA

Assistant Professor (Sr.G)
Area: Molecular Cell Biology, Physiology, Immunology
Affiliation: Department of Genetic Engineering, Kattankulathur Campus, SRM Institute of Science and Technology (formerly known as SRM University)
Email ID: satishr@srmist.edu.in

Education

Other Details:

Courses

• Molecular Cell Biology
• Physiology
• Immunology
• Gene Therapy
• Developmental Genetics

Research Interests

• Cancer Biology
• Stem Cell Biology
• Molecular Biology
• Pharmacology
• Toxicology
• Natural Medicine and Drug Discovery

Selected Publications

• Paramita P, Subramaniam VD, Murugesan R, Gopinath M, Ramachandran I, Ramalingam S, Sun XF, Banerjee A, Marotta F, Pathak S. Evaluation of potential anti-cancer activity of CL-LC in colon cancer cells. 2018. IET Nanobiotechnology . doi: 10.1049/iet-nbt.2017.0106. [IF-1.463]
• Palaniappan A, Ramar K, Ramalingam S. Computational Identification of Novel Stage-Specific Biomarkers in  Colorectal Cancer Progression. 2016; PLoS One 11 (5), e0156665. PMID: 27243824 [IF-2.806].
• Rangarajan P, Subramaniam D, Paul S, Kwatra D, Palaniyandi K, Islam S, Harihar S, Ramalingam S, Gutheil W, Putty S, Pradhan R, Padhye S, Welch DR, Anant S, Dhar A. Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells. 2015; Oncotarget. Sep 29;6(29):27661-73. PMID: 26317547 [IF-5.168].
• Kaushik, G., Ramalingam, S., Subramaniam, D., Rangarajan, P., Protti, P., Rammamoorthy, P., Anant, S., Mammen, JM. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells. Am J Surg. 2012 Dec; 204(6): 868-73. PMID: 23231930 [IF-2.403].
• Moriasi, C., Subramaniam, D., Awasthi, S., Anant, S., Ramalingam, S. Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor. Anticancer Agents Med Chem. 2012 Dec 1; 12(10): 1221-38. PMID: 22583410 [IF-2.598].
• Ponnurangam, S., Mammen, J.M., Ramalingam, S., He, Z., Zhang, Y., Umar, S., Subramaniam, D., Anant, S. Honokiol in combination with radiation targets Notch signaling to inhibit colon cancer stem cells. Mol Cancer Ther. 2012 Apr;11(4):963-72. PMID: 22319203 [IF-5.764].
• Ramachandran, I., Thavathiru, E., Ramalingam, S., Natarajan, G., Mills, WK., Benbrook, D.M., Zuna, R., Lightfoot, S., Reis, A., Anant, S., Queimado, L. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene. 2012 May 31;31(22):2725-37. PMID: 22002305 [IF-7.519].
• He, Z., Subramaniam, D., Ramalingam, S., Dhar, A., Postier, R.G., Umar, S., Zhang, Y., Anant, S. Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. Amer J. Physiol.-GI and Liver Physiology 2011 Nov;301(5):G929-37. PMID: 21836060 [IF-3.468].
• Subramaniam, D, Ramalingam, S., Linehan, D.C., Dieckgraefe, B.K., Postier, R.G., Houchen, C.W., Jensen, R.A., and Anant, S. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. PLoS One, 2011 Feb, 6(2):e16958. PMID: 21347286 [IF-2.806].
• Subramaniam, D., Ramalingam, S., Houchen, C.W., Anant, S. Cancer stem cells: a novel paradigm for cancer prevention and treatment. Mini Rev Med Chem. 2010 May; 10(5): 359-71. PMID: 20370703 [IF-2.661].
• Pantazis, P., Varman, A., Simpson-Durand, C., Thorpe, J., Ramalingam, S., Subramaniam, D., Houchen, C., Ihnat, M., Anant, S., Ramanujam, R.P. Curcumin and turmeric attenuate arsenic-induced angiogenesis in ovo. Altern Ther Health Med. 2010 Mar-Apr; 16(2): 12-4. PMID: 20232614 [IF-1.329].
• Sureban, S.M., May, R., Ramalingam, S., Subramaniam, D., Natarajan, G., Anant, S., Houchen, C.W. Selective Blockade of DCAMKL-1 Results in Tumor Growth Arrest by a Let-7a MicroRNA-Dependent Mechanism. Gastroenterology, 2009, 137(2): 649-659. PMID: 19445940 [IF-18.392].
• Sureban, S.M*, Ramalingam, S*, Natarajan, G., May, R., Subramaniam, D., Bishnupuri, K.S., Morrison, A.R, Dieckgraefe, B.K., Houchen, C.W., and Anant, S. Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe. Oncogene, 2008, Jul 31; 27(33): 4544-56. PMID: 18427544 [IF-7.519]. *Equal contribution
• Natarajan, G., Ramalingam, S., Ramachandran, I., May, R., Queimade, L., Houchen, C.W., and Anant, S. Prostaglandin E2 suppressed CUGBP2 expression to protect colon cancer cells from radiation induced mitotic catastrophe. Amer J. Physiol.-GI and Liver Physiology, 2008, 294(5):G1235-44. PMID: 18325984 [IF-3.468].
• Sureban, S.M., May, R., George, R.J., Dieckgraefe, B.K., Ramalingam, S., Natarajan, G., Anant, S., and Houchen, C.W. Knockdown of RNA binding protein musashi-1 (Msi-1) leads to tumor regression in vivo. Gastroenterology, 2008, 34(5):1448-1458. PMID:18471519 [IF-18.392].
• Subramaniam, D., Natarajan, G., Ramalingam, S., Ramachandran, I., May, R., Queimade, L., Houchen, C.W., and Anant, S. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2. Amer J. Physiol.-GI and Liver Physiology, 2008, 294:G971-G981. PMID: 18427544 [IF-3.468].
• Ramalingam, S., Natarajan, G., Schafer, C., May, R., Ramachandran, I., Queimade, L., Houchen, C.W., and Anant, S. Novel intestinal splice variants of RNA binding protein CUGBP2: isoform specific effects on mitotic catastrophe. Amer J. Physiol.-GI and Liver Physiology. 2008, 294:G1025-G1032. PMID:18258790 [IF-3.468].
• Subramaniam, D., Ramalingam, S., May, R., Dieckgraefe, B.K., Berg, D.E., Pothoulakis, C., Houchen, C.W., Wang, T.F., and Anant, S. Gastrin mediated IL-8 and COX-2 gene expression: differential transcriptional and posttranscriptional mechanisms. Gastroenterology, 2008, 134(4):1070-1082. PMID: 18395088 [IF-18.392].

Books Published

• Sainathan, S., Paul, S., Ramalingam, S., Baranda J., Anant S., Dhar, A. Histone Demethylases in Cancer. In: Eckert, RL (Eds.) Epigenetics and Phytochemicals. Springer Netherlands, 2015, Curr Pharmacol Rep., 1-11.
• Ramalingam, S., Dhar, A., Anant, S. Epigenetic Signatures of Breast Cancer Genes.  In: Fazlul H. Sarkar (Eds.), Epigenetics and Cancer, Springer Netherlands, 2013, pp167-202.

Indexed Published

• Ramalingam, S., Subramaniam, D., Anant, S. Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and Chemotherapy. Curr Pharmacol Rep. 2015 Jun 1;1(3):141-153. PMID: 26029495.
• Paul, S., Ramalingam, S., Subramaniam, D., Baranda, J., Anant, S., Dhar, A. Histone Demethylases in Colon Cancer. Curr Colorectal Cancer Rep. 2014; Dec 1;10(4):417-424. PMID: 25574158.
• Ramalingam, S., Ramamoorthy, P., Subramaniam, D., and Anant, S. Reduced expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer. Immuno-Gastroenterology, 2012; July,1(1), 27-33, ISSN: 2224-7696. PMID: 23795348.
• Anant, S., Houchen, C.W., Pawar, V., and Ramalingam, S. Role of RNA-Binding Proteins in Colorectal Carcinogenesis. Curr Colorectal Cancer Rep. 2010 Mar 2; c6(2):68-73. PMID: 21285251.

Patents

• Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof.
  Patent number: 8936941
  Abstract: DCAMKL-1 has been identified as a biomarker for stem cells, as well as cancer stem cells. Methods of detecting the presence of at least one stem cell, methods of isolating stem cells, and methods of inhibiting growth of cancer cells utilizing DCAMKL-1 are disclosed herein.
  Filed: February 15, 2011, Issued: January 20, 2015
  Assignee: The Board of Regents of the University of Oklahoma
  Inventors: Shrikant Anant, Courtney Houchen, Satish Ramalingam, Rama Ramanujam, Dharmalingam Subramaniam.

• Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same
  Patent number: 7902166
  Abstract: Compositions for inhibiting RNA binding proteins, as well as methods of producing and using the same, are disclosed herein.
  Filed: April 20, 2009, Issued: March 8, 2011
  Assignee: The Board of Regents of the University of Oklahoma
  Inventors: Courtney Houchen, Shrikant Anant, Sripathi M. Sureban, Satish Ramalingam, Dhamalingam Surbramaniam, Rama P. Ramanujam.

• In vitro tumor in dish kit and method
  Patent number: 9494573
  Abstract: This invention is a method and kit for preparing a Tumor in Dish model for use in screening anti-cancer agents and analyzing cancer growth and development.
  Filed: May 20, 2013, Issued: November 15, 2016
  Assignee: University Of Kansas
  Inventors: Shrikant Anant, Prabhu Ramamoorthy, Satish Ramalingam, Gurusingham Sitta Sittampalam.

• A Method and Process for the Efficacy Enhancement of Activities of Bioflavonoids
  Application number: 201741001089
  Abstract: The clinical use of Bioflavonoids was restricted because of their poor water solubility. In this regard, we have synthesized the Bioflavonoid nanoparticle by covalently conjugating folic acid with chitosan molecules (as a carrier) through the γ-carboxyl moiety. In addition, this process allows the bioflavonoid to actively target the cancer cells by targeting the Folate receptors that is over expressed in various cancer cells.
  Filed: Jan 11, 2017
  Assignee: Chettinad University
  Inventors: Satish Ramalingam, Shoba Narayan, Surajit Pathak, Lizha Mary.

Papers Presented

• Lizha Mary, Surajit Pathak, Ilangovan Ramachandran, Shoba Narayan, Satish Ramalingam. 2017. A novel design of Hesperetin encapsulated chitosan-folate nanoparticle for colon cancer therapy. National Seminar on Advanced Biomaterials and Applications, Hindustan University, Chennai, Tamil Nadu, India.
• Dharmalingam Subramanian, Sivapriya Ponnurangam, Deep Kwatra, Gaurav Kaushik, Prabhu Ramamoorthy, Satish Ramalingam, Ossama Tawfik, Scott Weir, Subhash Padhye, Dan Dixon, Shahid Umar, Roy
• Jensen, and Shrikant Anant. 2015. Honokiol prevents colonic tumorigenesis and affects stem cell viability by affecting oncogenic YAP1 function. American Association of Cancer Research Annual meeting, Philadelphia, PA.
• Satheesh Sainathan, Santanu Paul, Kanagaraj Palaniyandi, Dharmalingam Subramaniam, Satish Ramalingam, Ossama Tawfik, Tomoo Iwakuma, Danny Welch,  Subash Padhye, Shrikant Anant, and Animesh Dhar. 2014. Histone Demethylase KDM3A: Novel Epigenetic Target for Pancreatic Cancer. American Association of Cancer Research Annual meeting, Philadelphia, PA.
• Kanagaraj Palaniyandi, Santanu Paul, Parthasarathy Rangarajan, Deep Kwatra, Satish Ramalingam, Dharmalingam Subramaniam, Tomoo Iwakuma, Subhash Padhye, Shrikant Anant, and Animesh Dhar. 2014. Histone demethylase JMJD1a: A Novel Therapeutic Target for Pancreatic cancer. 105th American Association of Cancer Research Annual meeting, San Diego, CA.
• Dharmalingam Subramanian, Sivapriya Ponnurangam, Deep Kwatra, Shahid Umar, Satish Ramalingam, Dan Dixon, Roy Jensen, Subhash Padhye, and Shrikant Anant. 2013. Honokiol prevents colonic tumorigenesis and affects stem cell viability in part through suppression of oncogenic YAP1. 12th Annual AACR International Conference on Frontiers in Cancer Prevention Research, National Harbor, MD.
• Dharmalingam Subramaniam, Ravi Thombre, Sivapriya Ponnurangam, Shahid Umar, Satish Ramalingam, Roy Jensen, and Shrikant Anant. 2013. Curcumin prevents intestinal tumorigenesis in APCmin/+ mice and affects stem cell viability by affecting oncogenic YAP1 function. 12th Annual AACR International Conference on Frontiers in Cancer Prevention Research, National Harbor, MD.
• Parthasarathy Rangarajan, Sydney Byrne, Satish Ramalingam, Dharmalingam Subramanian, Sivapriya Ponnurangam, Prabhu Ramamoorthy, Shrikant Anant, Roy Jensen. Gedunin induces AMPK mediated autophagy, a novel form of mitotic catastrophe. 2013.  Twelfth Annual AACR International Conference on
Frontiers in Cancer Prevention Research
October 27-30, National Harbor, MD.
• Dharmalingam Subramanian, Sivapriya Ponnurangam, Shahid Umar, Satish Ramalingam, Roy Jensen, Shrikant Anant. Honokiol affects stem cell viability in part through suppression of Hippo signaling pathway. 2013. American Association for Cancer Research Annual meeting, Washington, DC.
• Prabhu Ramamoorthy, Sydney Byrne, Satish Ramalingam, Parthasarathy Rangarajan, Dharmalingam Subramanian, Shrikant Anant, Roy Jensen. 2013. Effects of Hsp90 inhibitors on triple negative breast cancer:
• Notch as a therapeutic target for stem cells. 2013. Twelfth Annual AACR International Conference on
Frontiers in Cancer Prevention Research
October 27-30, National Harbor, MD.
• Satish Ramalingam, Dharmalingam Subramaniam, Shrikant Anant. RBM3 drives tumor angiogenesis by modulating miR-210. 2013. American Association for Cancer Research Annual meeting, Washington, DC.
• Satish Ramalingam, Dharmalingam Subramanian, David Standing, Naveen Nerudagomma, Shahid Umar, Shrikant Anant. 2012. RNA binding protein RBM3 promotes metastasis through induction of hemangiogenesis and lymphangiogenesis. AACR, Chicago, IL.
• Dharmalingam Subramanian, Sivapriya Ponnurangam, Satish Ramalingam, Shrikant Anant. 2012. Honokiol inhibits colon cancer stem cell growth and mechanism mediated through Notch signaling pathway. AACR, Chicago, IL.
• Cate Moriasi, Catherine Trevino, Dharmalingam Subramaniam, Satish Ramalingam, Vibhudhutta Awasthi, Shanjana Awasthi, and Shrikant Anant. 2011. Curcumin regulates Interleukin-6 expression in colon cancer cells. AACR Annual Meeting, Orlando, FL.
• Anand Venugopal, Satish Ramalingam, Dharmalingam Subramaniam, Zhiyun He, Roy A. Jensen, and Shrikant Anant. 2011. Novel Splicing Activity for RNA Binding Protein CUGBP2 in Radiation-induced Mitotic Catastrophe. AACR Annual Meeting, Orlando, FL.
• Elizabeth Moran, Satish Ramalingam, Dharmalingam Subramaniam, Cate Moriasi, Shrikant Anant. 2011. RBM3 prevents radiation-induced mitotic catastrophe by promoting anaphase. AACR Annual Meeting, Orlando, FL.
• Satish Ramalingam, Dharmalingam Subramaniam, Roy A. Jensen, Shrikant Anant. 2011.  RBM3 overexpression promotes cancer stem cell expansion through activation of Notch-1 signaling. AACR Annual Meeting, Orlando, FL.
• Satish Ramalingam, Dharmalingam Subramaniam, Zhiyun He, Courtney W. Houchen, and Shrikant Anant. 2011.  Radiation induced autophagic cell death of colon cancer cells in part through increasing RNA binding protein CUGBP2 expression. Digestive Disease Week, Chicago, IL.
• Shrikant Anant, and Satish Ramalingam. 2010. RNA binging protein inhibiting tumor progression and metastasis. International Cancer Research Symposium, Trivandrum, India.
• Dharmalingam Subramaniam, Satish Ramalingam, Roy A. Jensen, Shrikant Anant, S. 2010. RNA binding protein CUGBP2/CELF2 mediates curcumin induced mitotic catastrophe of pancreatic cancer cells. The University of Kansas Cancer Center Research Symposium, Kansas City, KS.
• Elizabeth Moran, Satish Ramalingam, Dharmalingam Subramaniam, Cate Moriasi, and Shrikant Anant. 2010. RBM3 Prevents Radiation-Induced Mitotic Catastrophe By Promoting Anaphase. The University of Kansas Cancer Center Research Symposium, Kansas City, KS.
• Satish Ramalingam, Dharmalingam Subramaniam, Roy A. Jensen, Shrikant Anant, S. 2010. RBM3 overexpression promotes cancer stem cell expansion through activation of Notch-1 signaling. The University of Kansas Cancer Center Research Symposium, Kansas City, KS.
• Satish Ramalingam, Dharmalingam Subramaniam, Gopalan Natarajan, Ilangovan Ramachandran, Randal May, Lurdes Queimado, Stanley Lightfoot, Courtney Houchen and Shrikant Anant. 2010. Inhibition of Metastasis: a Novel Role for RNA Binding Protein CUGBP2. AACR Meeting Abstracts, 2347, Washington DC.
• Satish Ramalingam, Dharmalingam Subramaniam, Elizabeth Moran, Ilangovan Ramachandran, Lurdes Queimado, Courtney W. Houchen, Shrikant Anant. 2010. Role of RNA Binding Protein CUGBP2 in Radiation-Mediated Autophagy. Digestive Disease Week 2010, 554, Lousiana, New Orleans.
• Satish Ramalingam, Dharmalingam Subramaniam, Randal May, Courtney W. Houchen, Shrikant Anant. 2009. CUGBP2 overexpression induces autophagy in colon cancer cells when radiation-induced mitotic catastrophe is inhibited. Digestive Disease Week 2009, 597432, Chicago, IL.
• Satish Ramalingam, Gopalan Natarajan, Randal May, Stan A. Lightfoot, Vibhudutta Awasthi, Courtney W. Houchen, Shrikant Anant. 2009. Overexpression of proto-oncogene RBM3 induces potent tumor formation by converting normal cells to cancer stem cells. Digestive Disease Week 2009, 597283, Chicago, IL.
• Sripathi M. Sureban, Randal May, Satish Ramalingam, Dharmalingam Subramaniam, Gopalan Natarajan, James H. Wyche, Shrikant Anant, Courtney W. Houchen. 2009. Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a microRNA dependent mechanism. Digestive Disease Week 2009, 596934, Chicago, IL.
• Satish Ramalingam, Dharmalingam Subramaniam, Cindy Simpson, Aarthi Varman, Courtney W. Houchen, Shrikant Anant. 2009. RBM3 mediated up regulation of miR210 induces angiogenesis and is a potential target for anti-angiogenic compound marmelin.  AACR Meeting Abstracts, LB-287, Denver, Colorado.
• Monica Draper, Sripathi M. Sureban, Satish Ramalingam, Gopalan Natarajan, Courtney W. Houchen, Shrikant Anant. 2008. Epidermal Growth Factor induces expression of protooncogene RBM3 through p38 and ERK resulting in increased COX2 expression. Digestive Disease Week, S1645, San Diego, California.
• Tauseef Ali, Satish Ramalingam, Dharmalingam Subramaniam, Randal May, Courtney W. Houchen, Shrikant Anant. 2008. Abrogation of experimental colitis by turmeric correlates with reduction in NFκB nuclear translocation and COX2 expression. ACG, Orlando, Florida.
• Dharmalingam Subramaniam, Satish Ramalingam, Ilangovan Ramachandran, Lurdes Queimado, Courtney W. Houchen, Shrikant Anant. 2008. Translation control during mitotic catastrophe: Mcl-1 is a novel target for the RNA binding protein CUGBP2. Digestive Disease Week, San Diego, California.
• Gopalan Natarajan, Satish Ramalingam, Ilangovan Ramachandran, Lurdes Queimado, Courtney W. Houchen, Shrikant Anant. 2008. Inhibition of CUGBP2 by prostaglandin E2 suppresses radiation-mediated mitotic catastrophe in colon cancer cells. Digestive Disease Week, 445278, San Diego, California.
• Satish Ramalingam, Gopalan Natarajan, Chris Schafer, Randal May, Ilangovan Ramachandran, Lurdes Queimado, Courtney W. Houchen, Shrikant Anant. 2008. Novel intestinal splice variants of RNA binding protein CUGBP2: Isoform specific effects on mitotic catastrophe. Digestive Disease Week 2008, 445278, San Diego, California.
• Satish Ramalingam, Gopalan Natarajan, Randal May, Courtney W. Houchen, Shrikant Anant. 2008. RNA translation enhancing protein RBM3 is a novel protooncogene that induces anchorage independent growth. Digestive Disease Week, 445186, San Diego, California.
• Satish Ramalingam, Gopalan Natarajan, Randal May, Courtney W. Houchen, Shrikant Anant. 2008. RNA binding protein RBM3 is a novel protooncogene. AACR Meeting Abstracts, 1794, San Diego, California.
• Satish Ramalingam, Dharmalingam Subramaniam, Brian K. Deikgraefe, Courtney W. Houchen, Shrikant Anant. 2007. Switch in spliced variants coupled with decreased translation: A novel method of EGF mediated suppression of CUGBP2 expression in tumorigenesis. Digestive Disease Week, Washington DC.
• Nabendu Murmu, Satish Ramalingam, Dharmalingam Subramaniam, James Wyche, Courtney W. Houchen, Shrikant Anant. 2007. Synergistic effect of curcumin and COX2 inhibition in regulating colon cancer cell proliferation. AACR Meeting Abstracts, 5133, San Diego, California.
• Satish Ramalingam, Gopalan Natarajan, Sripathi M. Sureban, Randal May, Courtney W. Houchen, Shrikant Anant. 2007. RNA binding RBM3: A novel protooncogene required for tumor cells to overcome G2/M arrest and mitotic catastrophe. AACR Cytoskeleton Meeting, 6960, San Diego, California.
• Sripathi Sureban, Dharmalingam Subramaniam, Kathy Lee, Satish Ramalingam, Aubrey Morrison, Brian Dieckgraefe, Courtney Houchen, and Shrikant Anant. 2006. Posttranscriptional regulation of COX-2 gene expression in intestinal tumorigenesis: Role of novel protooncogene RBM3. Oral Presentation, Digestive Disease Week, Los Angeles, CA.
• Satish Ramalingam, Courtney W. Houchen, Brian K. Deikgraefe, Shrikant Anant. 2006. Differential promoter usage and activity may regulate function of RNA binding protein CUGBP2 in intestinal epithelial cells. Digestive Disease Week, Los Angeles, California.
• Satish Ramalingam, Rengasamy Dhananjayan. 2003. Effect of Alpinia galanga Linn. on lipid peroxidation and non-enzymic antioxidants in Wistar albino rats. International conference on the role of free radicals and Anti-oxidants on Health and Disease and II Annual conference of SFRR, Lucknow, India.
• Satish Ramalingam, Rengasamy Dhananjayan. 2003. Neuropharmacological effects of extracts from Alpinia galanga Linn. International conference on the role of Indian systems of Medicine and   Homeopathy in the 21st century, Chennai, India.

Workshops /Seminars/Conferences:

• Organizer, Workshop on "Pre-clinical Screening Methods for Anticancer Agents" on the 7th of July 2016, at Chettinad Academy of Research and Education.
• Organizer, National seminar on, "Targeting Cancer Stem Cells – A Novel Approach for Cancer Therapy" on July 2016, at Chettinad Academy of Research and Education.
• Coordinator, SERB Expert Committee Meeting – Life Sciences on Dec 2nd & 3rd, 2016, at Chettinad Academy of Research and Education.
• Organizing Committee Member, National Workshop on Cellular & Molecular Diagnostics on 10th & 11th February 2017, at Chettinad Academy of Research and Education.
• Organizing Committee Member, National Conference on Recent Trends in Genetic Engineering and Biotechnology on 25th & 26th September 2017, at Department of Genetic Engineering, SRM University.
• Organizer, Workshop on Basic Animal Cell Culture on 9th March 2018, at Department of Genetic Engineering, SRM Institute of Science and Technology

Working Papers:

• Lizha Mary, L., Vasantha Kumar, M., and Satish R. Cancer stem cells as a seed for cancer metastasis, at Stem Cell Investigation, 2018.

Work in progress:

• Jacob New, Satish Ramalingam, Dharmalingam Subramaniam, Sivapriya Ponnurangam, Prabhu Ramalingam, David Standing, Dan Dixon, Shahid Umar, Sufi Mary Thomas, and Shrikant Anant. CELF2 Promotes Autophagy and Sustains Colorectal Cancer Radiotherapy. Under Preparation

Academic Experience:

• Associate Professor, Department of Allied Health Sciences, Chettinad University, 2005-2007.
• Assistant Professor for Research, Department of Physiology, University of Kansas Medical Center, 2010-2015.

Other professional Experiences

• Post-Doctoral Research Associate, Department of Medicine, Division of Digestive Diseases and Nutrition, Oklahoma University of Health Sciences Centre, Oklahoma City, OK. 2006-2010.
• Post-Doctoral Research Fellow, Department of Internal Medicine, Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO. 2005-2006.
• Post-Doctoral Research Fellow, Departments of Pharmaceutical and Administrative Sciences, Nova Southeastern University, Ft. Lauderdale, FL. 2005.

Achievements and Awards

• First Rank, M. Sc., University of Madras, 1999
• University Research Fellowship, 2003
• Senior Research Fellowship, Council for Scientific and Industrial Research, Government of India, 2004
• Sri Nageswara Rao Pantulu Prize for the Best Research Paper in the field of Medicine, University of Madras, 2004
• GRG/AGA Fellow Travel Award in Digestive Diseases Week, 2006
• Poster of Distinction Award in Digestive Diseases Week, 2009
• Junior Faculty Poster Competition Award Winner – 2nd Place in KUCC Research Symposium, 2010
• Poster of Distinction awarded for Digestive Disease Week, 2011
• Travel award for attending the Annual American Association of Cancer Research Meeting, Kansas University Medical Center Research Institute, 2011
• Junior Faculty Poster Competition Award Winner – 1st Place in KUCC Research   Symposium, 2011
• Travel award for attending Digestive Diseases Week Meeting, Kansas University Medical Center Research Institute, 2015

Memberships

• American Gastroenterology Association, 2006
  American Association for Cancer Research, 2007
  Society for Reproductive Biology and Comparative Endocrinology, 2016